BR0015425A - N-aril-( homopiperazinil )-ciclohexilaminas como transportadoras de 5-ht - Google Patents
N-aril-( homopiperazinil )-ciclohexilaminas como transportadoras de 5-htInfo
- Publication number
- BR0015425A BR0015425A BR0015425-3A BR0015425A BR0015425A BR 0015425 A BR0015425 A BR 0015425A BR 0015425 A BR0015425 A BR 0015425A BR 0015425 A BR0015425 A BR 0015425A
- Authority
- BR
- Brazil
- Prior art keywords
- alkyl
- aryl
- carriers
- carbon atoms
- substitutable
- Prior art date
Links
- 239000000969 carrier Substances 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 abstract 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- -1 nitro, amino Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
"N-ARIL-(HOMOPIPERAZINIL)-CICLOHEXILAMINAS COMO TRANSPORTADORAS DE 5-HT" A presente invenção refere-se a novos compostos e métodos e composições usando os mesmos no tratamento de distúrbios do sistema nervoso central, incluindo depressão e ansiedade, os compostos tendo a fórmula (I), em que Ar representa um grupo arila, arilalquila ou heteroarila; R~ 1~ e R~ 2~ são independentemente selecionados de hidrogênio, alquila de 1 a 12 átomos de carbono que pode ser substituído por cicloalquila de 3 a 10 átomos de carbono, que pode ser substituído; R~ 3~ é H, alquila que pode ser substituído, alquila cíclica que pode ser substituído, halogênio, alcóxi, haloalquila, OH, nitro, amino, CN, carbóxi, alcoxicarbonila, alquilcarbonila, aminocarbonila e alquilaminocarbonila, ou um sal farmaceuticamente aceitável dos mesmos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43612999A | 1999-11-08 | 1999-11-08 | |
| PCT/US2000/014020 WO2001034597A1 (en) | 1999-11-08 | 2000-05-19 | N-aryl-(homopiperazinyl)-cyclohexyl amines as 5-ht transporters |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0015425A true BR0015425A (pt) | 2002-07-16 |
Family
ID=23731225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0015425-3A BR0015425A (pt) | 1999-11-08 | 2000-05-19 | N-aril-( homopiperazinil )-ciclohexilaminas como transportadoras de 5-ht |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1228064A1 (pt) |
| JP (1) | JP2003513969A (pt) |
| CN (1) | CN1420883A (pt) |
| AU (1) | AU5152300A (pt) |
| BR (1) | BR0015425A (pt) |
| CA (1) | CA2390530A1 (pt) |
| MX (1) | MXPA02004554A (pt) |
| WO (1) | WO2001034597A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0103649D0 (sv) * | 2001-11-01 | 2001-11-01 | Astrazeneca Ab | Therapeutic quinoline compounds |
| SE0103648D0 (sv) * | 2001-11-01 | 2001-11-01 | Astrazeneca Ab | Therapeutic quinolone compounds |
| JP2007106746A (ja) * | 2005-09-13 | 2007-04-26 | Tosoh Corp | 新規アリールホモピペラジン類、またはその塩と製造方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4954502A (en) * | 1988-06-10 | 1990-09-04 | Bristol-Myers Squibb Company | 1-indolyalkyl-4-(substituted-pyridinyl)piperazines |
| DK0946538T3 (da) * | 1996-12-20 | 2003-11-03 | Lundbeck & Co As H | Indan- eller dihydroindole derivater |
-
2000
- 2000-05-19 JP JP2001536544A patent/JP2003513969A/ja active Pending
- 2000-05-19 CA CA002390530A patent/CA2390530A1/en not_active Abandoned
- 2000-05-19 AU AU51523/00A patent/AU5152300A/en not_active Abandoned
- 2000-05-19 BR BR0015425-3A patent/BR0015425A/pt not_active Application Discontinuation
- 2000-05-19 WO PCT/US2000/014020 patent/WO2001034597A1/en not_active Ceased
- 2000-05-19 MX MXPA02004554A patent/MXPA02004554A/es unknown
- 2000-05-19 CN CN00818247A patent/CN1420883A/zh active Pending
- 2000-05-19 EP EP00936166A patent/EP1228064A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CN1420883A (zh) | 2003-05-28 |
| WO2001034597A1 (en) | 2001-05-17 |
| MXPA02004554A (es) | 2004-09-10 |
| AU5152300A (en) | 2001-06-06 |
| EP1228064A1 (en) | 2002-08-07 |
| JP2003513969A (ja) | 2003-04-15 |
| CA2390530A1 (en) | 2001-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA31521B1 (fr) | Dérivés de 2,3-dihydrobenzo[1,4] dioxin-2-ylméthyle utilisés en tant qu'antagonistes des alpha2c pour traiter des maladies des systèmes nerveux périphérique et central | |
| BRPI0507984B8 (pt) | composto ou um sal do mesmo, processo para produzir um composto, medicamento, métodos para antagonizar angiotensina ii em um mamífero, para melhorar a resistência de insulina em um mamífero e para prevenir ou tratar doenças circulatórias em um mamífero, e, uso do composto | |
| BR0215429A (pt) | Composto de fórmula i e seus usos, métodos de inibição da atividade e método de inibição da ativação de um receptor de monoamina, métodos de tratamento, método de identificação de polimorfismo genético e método de identificação de paciente | |
| BRPI0407976A (pt) | tetrahidroisoquinolinas substituìdas em 2,5 e 2,6 para uso como moduladores de 5-ht6 | |
| BRPI0818193B8 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BR0317273A (pt) | Utilizações farmacêuticas para ligandos alfa2delta | |
| AP1822A (en) | Substituted pyridinones as modulators of P38 MAP kinase. | |
| MX2010000617A (es) | Compuestos y metodos para modulacion de cinasa, e indicaciones de estos. | |
| TW200613306A (en) | Imidazotriazines as protein kinase inhibitors | |
| NO20062139L (no) | Dihydrobenzofuranyl-alkanaminderivater som 5HT2C-agonister | |
| BRPI0509364B8 (pt) | derivados de tetraidroquinolina, composição farmacêutica que os compreende e um processo por preparar os referidos derivados | |
| BR9810829A (pt) | Composto, processo para preparar o mesmo, composição, uso de um composto ou um sal farmaceuticamente aceitável do mesmo ou uma composição, e, processo de tratamento de uma condição | |
| BR9808552A (pt) | Composto tricìclico ou um sal farmaceuticamente aceitável do mesmo, e, composição farmacêutica | |
| BR0317705A (pt) | Composto, formulação farmacêutica, uso de um composto, método de tratamento de doenças ou condições, e, processo para a preparação de compostos | |
| BR0210733A (pt) | Derivados de piperidina de utilidade úteis como moduladores da atividade do receptor de quimocina | |
| TW200716084A (en) | Methods for treating sleep-wake disorders | |
| BRPI0408591A (pt) | derivados de 6,7,8,9-tetrahidropirimido[1,2-a] pirimidin-4-ona 8-substituìda | |
| BRPI0411285A (pt) | composto, processo para preparar um composto formulação farmacêutica, uso de um composto, e, método de prevenção ou tratamento de distúrbios | |
| BRPI0518233A2 (pt) | terapia adjunta para depressço | |
| BRPI0417520A (pt) | 1h-pirrolo[3,2-b, 3,2-c, e 2,3-c]piridina-2-carboxamidas substituìdas e análogos relatados como inibidores de caseìna cinase i-epsilon | |
| BR0310032A (pt) | Derivados de benzoxazina como moduladores de 5-ht6 e usos dos mesmos | |
| BR9912575A (pt) | Processo para a preparação de um composto, e, composto. | |
| BRPI0414241A (pt) | composto, composição farmacêutica, métodos para ativar receptores 5-ht1f em um mamìfero, para inibir o extravasamento de proteìna neuronal em um mamìfero e para tratar ou prevenir enxaqueca em um mamìfero, e, uso de um composto | |
| BRPI0408248A (pt) | derivados azabicìclicos de piridiloximetila e de benzisoxazol | |
| MY145066A (en) | Methods for treating sexual dysfunction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
| B11Y | Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired |